Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$52.06 - $58.9 $4.65 Million - $5.26 Million
-89,370 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$52.94 - $61.88 $968,537 - $1.13 Million
-18,295 Reduced 16.99%
89,370 $4.73 Million
Q4 2021

Feb 07, 2022

BUY
$55.41 - $63.3 $5.97 Million - $6.82 Million
107,665 New
107,665 $6.53 Million
Q2 2018

Aug 02, 2018

SELL
$28.49 - $38.41 $9.2 Million - $12.4 Million
-322,888 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$32.94 - $46.03 $1.79 Million - $2.5 Million
-54,255 Reduced 14.39%
322,888 $10.9 Million
Q4 2017

Jan 30, 2018

BUY
$40.63 - $50.91 $1.82 Million - $2.28 Million
44,882 Added 13.51%
377,143 $16.8 Million
Q3 2017

Oct 30, 2017

BUY
$48.69 - $53.63 $16.2 Million - $17.8 Million
332,261
332,261 $16.6 Million

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.4B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Mesirow Financial Investment Management Equity & Fixed Income Portfolio

Follow Mesirow Financial Investment Management Equity & Fixed Income and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.